BIOGEN INC. (BIIB) › RevenueBIOGEN INC. (BIIB) — RevenueAnnual figures by fiscal year, from SEC filings.2007: $3.17B2008: $4.10B2009: $4.38B2010: $4.72B2011: $5.05B2012: $5.52B2013: $6.93B2014: $9.70B2015: $10.76B2016: $11.45B2017: $12.27B2018: $13.45B2019: $14.38B2020: $13.44B2021: $10.98B2022: $10.17B2023: $9.84B2024: $9.68B2025: $9.89B$9.89B2007Revenue (USD)2025Fiscal YearRevenueChange YoY2025$9.89B+2.2%2024$9.68B-1.6%2023$9.84B-3.3%2022$10.17B-7.4%2021$10.98B-18.3%2020$13.44B-6.5%2019$14.38B+6.9%2018$13.45B+9.6%2017$12.27B+7.2%2016$11.45B+6.4%2015$10.76B+10.9%2014$9.70B+40.0%2013$6.93B+25.7%2012$5.52B+9.3%2011$5.05B+7.0%2010$4.72B+7.7%2009$4.38B+6.8%2008$4.10B+29.2%2007$3.17B—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share